What is the current Oragenics market capitalization?
The current market capitalization of Oragenics is 822,261.7 USD.
Oragenics Market capitalization 2024
Oragenics Market capitalization
822,261.7 USD
Ticker
OGEN
ISIN
US6840233026
WKN
A2JBK2
In 2024, Oragenics's market cap stood at 822,261.7 USD, a -93.81% increase from the 13.29 M USD market cap in the previous year.
The Oragenics Market capitalization history
| YEAR | Market Capitalization (undefined USD) |
|---|---|
| 2023 | 8.95 |
| 2022 | 37.6 |
| 2021 | 83.48 |
| 2020 | 34.7 |
| 2019 | 24.47 |
| 2018 | 17.24 |
| 2017 | 20.69 |
| 2016 | 30.8 |
| 2015 | 51 |
| 2014 | 73.12 |
| 2013 | 92.36 |
| 2012 | 36.97 |
| 2011 | 18.62 |
| 2010 | 53.09 |
| 2009 | 31.39 |
| 2008 | - |
| 2007 | - |
| 2006 | - |
| 2005 | - |
| 2004 | - |
Oragenics Aktienanalyse
What does Oragenics do?
Oragenics Inc is a biopharmaceutical company that focuses on the development of innovative technologies and products for the prevention and treatment of oral and systemic infectious diseases. The company was founded in 1996 as a private company and has since had an impressive track record in the development of diagnostic tools and therapeutics for various diseases in different fields. The company's business model is based on the identification and development of therapeutics that leverage innovative technologies such as bacterial toxins and probiotics. Their products aim to address both the causes of disease formation and the symptoms, contributing to improved patient well-being. Oragenics maintains partnerships and collaborations with other companies and research institutions to enhance its research and development efforts. The company is divided into multiple divisions, including the development of probiotic bacterial groups with specific immunotherapeutic functions, the development of biopharmaceutical products for the treatment of infectious diseases, and the development of diagnostics and screening tools for identifying oral infections. Oragenics has developed a range of products and technologies that can contribute to the improvement of oral and overall health, including a Streptococcus mutans detection system for dentists to identify and combat bacteria in the patient's mouth. One notable product is the TerraCoV2 COVID-19 vaccine, developed in collaboration with the National University of Singapore. Overall, Oragenics Inc has a remarkable track record in the development of innovative technologies and products, emphasizing product quality, rational manufacturing, and a wide range of medical devices. The company works closely with partners and collaborators to intensify its research and development efforts and provide innovative solutions and products. Oragenics ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Oragenics's Market Capitalization
Oragenics's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Oragenics's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Oragenics's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Oragenics’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Oragenics stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Oragenics.
How has the market capitalization of Oragenics developed in recent years?
The market capitalization of Oragenics has increased/decreased by -93.81% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Oragenics?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Oragenics?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Oragenics have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Oragenics pay?
Over the past 12 months, Oragenics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Oragenics is expected to pay a dividend of 0 USD.
What is the dividend yield of Oragenics?
The current dividend yield of Oragenics is .
When does Oragenics pay dividends?
Oragenics pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Oragenics?
Oragenics paid dividends every year for the past 0 years.
What is the dividend of Oragenics?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Oragenics located?
Oragenics is assigned to the 'Health' sector.
Wann musste ich die Aktien von Oragenics kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Oragenics from 12/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/24/2024.
When did Oragenics pay the last dividend?
The last dividend was paid out on 12/24/2024.
What was the dividend of Oragenics in the year 2023?
In the year 2023, Oragenics distributed 0 USD as dividends.
In which currency does Oragenics pay out the dividend?
The dividends of Oragenics are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Oragenics
Our stock analysis for Oragenics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Oragenics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
